CCR5 antagonist for enhancing immune reconstitution and treating opportunistic infection in HIV patients

Details for Australian Patent Application No. 2007258907 (hide)

Owner Pfizer Products Inc.

Inventors Mayer, Howard Bernard

Agent Shelston IP

Pub. Number AU-A-2007258907

PCT Pub. Number WO2007/144720

Priority 60/821,974 10.08.06 US; 60/804,480 12.06.06 US; 60/888,387 06.02.07 US

Filing date 30 May 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/144720 Priority application(s): WO2007/144720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007258913-Adhesive mounting products and articles provided with mounting adhesive

2007258906-Expandable downhole tool